Featured Post From StockTwits About EXAS

$NDRA “It’s like a blood pressure cuff for NASH/NAFLD.” Fire sale at $58 million.

$EXAS a $25 Billion company to screen poop. $DXCM a $34 Billion company to screen glucose. Plus we have tons of companies to screen different type of cancer. Who will get the pie to screen liver disease? Might be a winner take all/most. I don’t see Endra being a mainstream name, but I do invision them licensing their tech to other companies and collecting royalties. A tree that keeps giving fruit forever? Those are the types that institutions buy, hold and keep for a long time. If Endra becomes that, might never need to sell it. 🌳

https://youtu.be/S_HtzqmUbCU